Thus, additional studies on MCT expression in other tumour types, confirmation of the results already published, as well as additional functional studies are needed to deeply understand the role of MCTs in cancer cell maintenance and aggressiveness and exactly in which cases these transporters could be used for therapy. The gene discussed is SLC16A1; the disease is neoplasm.